

QUICK LINKS
GSK-3beta Inhibitor VII is a phenyl alpha-bromomethyl ketone compound which acts as a cell-permeable, and non-ATP competitive inhibitor of glycogen synthase kinases (GSK-3beta) (IC = 0.5 muM). This compound acts as an alkylating agent that is selective towards GSK-3beta and does not affect PKA activity even at concentrations as high as 100 muM. Research has shown that glycogen synthase kinases have major roles in Wnt and Hedgehog signaling pathways and regulate the cell-division cycle, stem-cell renewal and differentiation, apoptosis, circadian rhythm, transcription and insulin action. This pertinent biological activity makes GSK inhibitors very useful research molecules.
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
2,4′-Dibromoacetophenone, 1 g | sc-506187B | 1 g | $15.00 | |||
2,4′-Dibromoacetophenone, 25 g | sc-506187 | 25 g | $124.00 | |||
2,4′-Dibromoacetophenone, 100 g | sc-506187A | 100 g | $416.00 | |||
2,4′-Dibromoacetophenone, 500 g | sc-506187C | 500 g | $1873.00 |